Rowe et al., 1981), sodium retention, decreased Na + , K + -ATPase activity, and increased GFR ( The etiology of IR in CKD is multifactorial, depending on classical and CKD-peculiar risk factors, such as physical inactivity, inflammation and oxidative stress, adipokine derangements, vitamin D deficiency, metabolic acidosis, anemia and microbial toxins (Spoto et al., 2016)
Growth HormoneReleasing Peptide-2
No equivalent switching trial has been published for the Wegovy pill, though as the same molecule as injectable Wegovy, that transition is conceptually simpler
Controls to validate the inhibitors used for these experiments are shown in Supplemetary Fig